References
- Bergsagel PL, Chesi M, Nardini E, et al (1996). Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Nat Acad Sci USA, 93, 13931-6. https://doi.org/10.1073/pnas.93.24.13931
- Blade J, Samson D, Reece D, et al (1998). Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol, 102, 1115-23. https://doi.org/10.1046/j.1365-2141.1998.00930.x
- De Larrea CF, Cibeira MT, Elena M, et al (2009). Abnormal serum free-light chain ratio in patients with multiple myeloma in long-lasting complete remission, strong association with oligoclonal bands. Haematologica, 94, 375.
- Gerritsen EJA, Vantol MJD, Lankester AC, et al (1993). Immunoglobulin levels and monoclonal, gammopathies in children after bone marrow transplantation. Blood, 82, 3493-502.
- Gerritsen EJA, Van tol MJD, Van't veer MB, et al (1994). Clonal dysregulation of the antibody response to tetanustoxoid after bone marrow transplantation. Blood, 84, 4374-82.
- Guikema JE, Vellenga E, Veeneman JM, et al (1999). Multiple myeloma related cells in patients undergoing autologous peripheral blood stem cell transplantation. Br J Haematol, 104, 748-54. https://doi.org/10.1046/j.1365-2141.1999.01233.x
- Hari PN, Zhang MJ, Roy V, et al (2009). Is the international staging system superior to the Durie-Salmon staging system? 10, 1038.
- Hovenga S, de Wolf JT, Guikema JE, et al (2000). Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses, a high incidence of oligoclonal serum Igs post transplantation. Bone Marrow Transplant, 25, 723-8. https://doi.org/10.1038/sj.bmt.1702194
- Kyle RA, Robinson RA, Katzmann JA (1981). The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med, 71, 999-1008. https://doi.org/10.1016/0002-9343(81)90326-0
- Maisnar V, Tichý M, Smolej L, et al (2007). Isotype class switching after transplantation in multiple myeloma. Neoplasma, 54, 225-8.
- Mariel EA, Leticia BM, Miguel AP, et al (2010). Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation, a 16-year experience. Clin Chem Lab Med, 48, 727-31.
- Mitus AJ, Stein R, Rappenport JM, et al (1989). Monoclonal and oligoclonal gammoppathy after bone marrow transplantation. Blood, 74, 2764-8.
- Sara L. H, Jill T, Devinder G, et al (2009). Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation. Clin Biochem Rev, 30, 113-8.
- Small TN, Keever CA, Weiner-fedus S, et al (1990). B-cell differentiation following autologous, conventional or T-cell depleted bone marrow transplantation, A recapitulation of normal B cell ontogeny. Blood, 76, 1647-56.
- Tormey WP (1998). Low concentration monoclonal and oligoclonal bands in serum and urine using the Sebia Hydragel Protein Electrophoresis System. Clin Chem Lab Med, 36, 253-4.
- Velardi A, Cucciaioni S, Terenzi A, et al (1988). Acquisition of Ag isotype diversity after bone marrow transplantation in adults, A recapitulation of normal B cell ontogeny. J Immunol, 141, 815-20.
- Vesole D, Vanier A, Flick J, et al (1992). Monoclonal immunoglobulin isotype switches in multiple myeloma patients following high high dose chemotherapy. Blood, 80, 122a.
- Zent CS, Wilson CS, Tricot G, et al (1998). Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood, 91, 3518-23.
Cited by
- Difficulties in immunofixation analysis: a concordance study on the IFM 2007-02 trial vol.3, pp.10, 2013, https://doi.org/10.1038/bcj.2013.51
- Oligoclonal bands in patients with multiple myeloma: Its emergence per se could not be translated to improved survival vol.105, pp.11, 2014, https://doi.org/10.1111/cas.12527
- Clinical Efficacy of Bevacizumab Concomitant with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3447
- Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma vol.93, pp.3, 2014, https://doi.org/10.1007/s00277-013-1890-2